Is MMR and MMRV the Same? Key Differences

MMR and MMRV are not the same vaccine, but they overlap significantly. MMR protects against three diseases: measles, mumps, and rubella. MMRV protects against those same three plus a fourth: varicella (chickenpox). The “V” in MMRV stands for varicella, and that’s the key difference between the two.

What Each Vaccine Contains

Both vaccines use live, weakened versions of the measles, mumps, and rubella viruses to train the immune system. The MMR vaccine comes in two brand-name versions (M-M-R II and PRIORIX), while the MMRV vaccine is sold as ProQuad. MMRV adds a live, weakened varicella-zoster virus to the mix, combining what would otherwise be two separate shots (MMR plus a standalone chickenpox vaccine) into one.

For families, the practical difference is simple: MMRV means one fewer injection for your child while still covering the same ground.

Who Can Get Each Vaccine

Both vaccines follow the same basic schedule. The CDC recommends a first dose at 12 to 15 months of age and a second dose at 4 to 6 years. The minimum age for either vaccine is 12 months.

The important distinction is that MMRV is only licensed for children ages 1 through 12. It cannot be given to anyone older than 12. MMR, on the other hand, has no upper age limit and is the version used for teenagers, adults, and anyone who needs a catch-up dose later in life. So if you’re an adult getting vaccinated, you’ll receive MMR (and a separate varicella shot if needed).

The Febrile Seizure Difference

MMRV carries a slightly higher risk of febrile seizures, the brief convulsions young children sometimes get with a fever. In the 7 to 10 days after the first dose, the seizure rate for MMRV is roughly twice as high as it is when MMR and varicella are given as separate shots. In concrete terms, that works out to about 1 additional febrile seizure for every 2,300 doses of MMRV given.

Febrile seizures are frightening to witness but are generally not harmful and don’t cause lasting problems. Still, this difference is why some pediatricians discuss the option with parents before the first dose. For the second dose, the seizure risk is comparable between MMRV and separate shots, so the combination vaccine is commonly used at the 4-to-6-year visit without the same concern.

How Well They Protect

The protection you get from MMR and MMRV against measles, mumps, and rubella is equivalent. One dose of either vaccine is about 93% effective against measles and 97% effective against rubella. A second dose pushes measles protection to roughly 97%, mainly by catching the small number of children whose immune systems didn’t respond the first time. Over 99% of children who complete both doses develop immunity to measles.

Mumps protection is the weakest link in both vaccines. Two doses are estimated to be between 66% and 95% effective, and immunity tends to fade over time. This is why mumps outbreaks still occasionally occur even in vaccinated populations.

For varicella specifically, MMRV provides the same level of protection as the standalone chickenpox vaccine. The combination doesn’t dilute or weaken any of the individual components.

Storage Requirements

This detail matters more for clinics than for parents, but it explains something you might notice at your child’s appointment. MMRV must be stored frozen, between -58°F and 5°F, because the varicella component is sensitive to temperature. MMR is more flexible and can be stored in either a refrigerator or a freezer. Not every clinic keeps a freezer stocked with MMRV, which is one reason some offices default to giving MMR and varicella as separate injections.

Which One Your Child Will Get

In practice, either approach provides the same protection. Your child will receive MMR plus a separate varicella shot (two injections) or MMRV (one injection). The total number of doses stays the same: two visits, at roughly 12 months and again before kindergarten. The choice often comes down to what the clinic stocks, the child’s age, and whether the provider recommends separate shots for the first dose to minimize the small febrile seizure risk. By the second dose, MMRV is the more convenient option with no meaningful safety tradeoff.